Damora Therapeutics Inc

$20.59
Market Cap 1.24B
ROE -122.0%
Gross Margin 0.0%
Debt/Equity 0.0
Current Ratio 22.5
Revenue QoQ 0.0%
EPS QoQ -0.7%
F-Score 3

About

Galecto Inc

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-5.33
vs median 35.63
P/B
2.45
vs median 2.25
ROE
-1.22
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

IMTXAVLNMRVIVIRGHRSMAZE
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics